GSK Turns To Profit In Q2; Signs Deal With 23andMe On New Medicines

(RTTNews.com) - GlaxoSmithKline plc (GSK, GSK.L) reported that its profit attributable to shareholders for the second-quarter was 441 million pounds or 8.9 pence per share, compared to a loss of 180 million pounds or 3.7 pence per share in the prior year.

Read more... https://www.nasdaq.com/article/gsk-turns-to-profit-in-q2-signs-deal-with-23andme-on-new-medicines-20180725-00375

How our body’s circadian clocks affect our health beyond sleep

"Everything cannot happen at once," says Satchin Panda, a circadian biologist at the Salk Institute for Biological Studies. This is true when it comes to experiences in the world, and it is also true when it comes to our bodies.

Read more... https://www.theverge.com/2018/6/12/17453398/sleep-circadian-code-satchin-panda-clock-health-science